Legend Biotech Corp (LEGN)
44.41
-0.76
(-1.68%)
USD |
NASDAQ |
Apr 25, 13:13
Legend Biotech Total Liabilities (Quarterly): 597.24M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 597.24M |
| September 30, 2023 | 499.70M |
| June 30, 2023 | 523.63M |
| March 31, 2023 | 556.20M |
| December 31, 2022 | 586.65M |
| June 30, 2022 | 460.11M |
| March 31, 2022 | 601.95M |
| December 31, 2021 | 353.52M |
| Date | Value |
|---|---|
| September 30, 2021 | 587.90M |
| June 30, 2021 | 535.21M |
| March 31, 2021 | 408.80M |
| December 31, 2020 | 124.32M |
| September 30, 2020 | 373.74M |
| June 30, 2020 | 371.86M |
| March 31, 2020 | 380.82M |
| December 31, 2019 | 410.58M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
124.32M
Minimum
Dec 2020
601.95M
Maximum
Mar 2022
460.76M
Average
479.91M
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 98.78B |
| Bristol-Myers Squibb Co | 65.67B |
| 2seventy bio Inc | 310.13M |
| Gilead Sciences Inc | 39.38B |
| Exelixis Inc | 678.44M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.849B |
| Shareholders Equity (Quarterly) | 1.251B |
| Debt to Equity Ratio | 0.2248 |
| Current Ratio | 6.921 |
| Net Debt Paydown Yield | -0.51% |